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Correction of hyperkalemia by bicarbonate despite constant
blood pH. Patients having hyperkalemia often are given bicarbo-
nate to raise blood pH and shift extracellular potassium into cells.
Blood pH in many hyperkalemic patients, however, is compensa-
ted. To determine whether bicarbonate, independent of its pH
action, affects plasma potassium. 14 hyperkalemic patients were
treated with bicarbonate in 5% dextrose. In five patients (changed
pH group), blood pH rose at least 0.08, while in nine (constant pH
group), it changed less than 0.04. In the first group, pH rose 0.12,
bicarbonate rose 5.9 mEq/liter, and plasma potassium fell 1.6 mEq/
liter, and plasma potassium fell 1.4 mEq/liter. The correlation
between changes in plasma potassium and bicarbonate was identi-
cal in the two groups and independent of urinary potassium excre-
tion. Four additional patients, who were treated with 5% dextrose
alone, did not significantly lower their plasma potassium, although
subsequent treatment with bicarbonate in 5% dextrose lowered
their plasma potassium. Thus, bicarbonate lowers plasma potas-
sium, independent of its effect on blood pH, and despite a risk of
volume overload, should be used to treat hyperkalemia in compen-
sated acid-base disorders, even in the presence of renal failure.
provided the plasma bicarbonate concentration is decreased.
Correction de l'hyperkaliémie par le bicarbonate malgré un pH
sanguin constant. Les malades en hyperkaliémie reçoivent sou-
vent du bicarbonate afin d'augmenter leur pH sanguin et de provo-
quer un passage de potassium dans les cellules. Pour savoir si le
bicarbonate. indépendamment de son action sur le pH. agit par lui-
méme sur Ia concentration plasmatique du potassium. quatorze
malades en hyperkaliémie ont été traités par du bicarbonate dans
du glucose a 5%. Chez cinq malades (groupe avec modification du
pH), Ic pH du sang a augmenté d'au moms 0,08 alors que chez les
neuf autres (groupe a pH constant) Ia modification a été inférieure
a 0,04. Dans Ic primier groupe Ic pH a augmenté de 0,12, Ic
bicarbonate a augmenté de 5,9 mEq/litre et Ic potassium plasma-
tique a diminué de 1,6 mEqllitre. Dans Ic deuxième groupe Ic pH
na augmenté que de 0,01; le bicarbonate a augmenté de 5,2 mEq/
litre et Ia concentration plasmatique de potassium a diminué de 1,4
mEq/litre. La correlation entre les modifications du potassium
plasmatique et du bicarbonate est Ia même dans les deux groupes,
dIe est indépendante de I'excrétion urinaire du potassium. Quatre
autres malades traités par Ic glucose seul n'ont pas eu
d'abaissement significatif de Ia kaliémie alors que Ic traitement
ultérieur par du bicarbonate dans du glucose a 5% a abaissé la
concentration plasmatique du potassium. Ainsi Ic bicarbonate
abaisse Ia concentration plasmatique du potassium indépendam-
ment de son effet sur le pH du sang et, malgré Ic risque de
surcharge, doit étre utilisé dans Ic traitment de l'hyperkaliemic
dans les situations oO léquilibre acido-basique est compensé et
méme s'il existe une insuffisance rénale, pour autant que Ia con-
centration plasmatique du bicarbonate soit diminuée.
Many studies have shown that raising blood pH
reduces the plasma potassium concentration, while a
decrease in blood pH elevates serum potassium
[1—4]. Bicarbonate, therefore, has long been advo-
cated for the treatment of hyperkalemia [5—7], based
on bicarbonate's ability to raise blood pH. Data from
the literature, however, are conflicting as to whether
bicarbonate, apart from its effect on blood pH, also
alters plasma potassium. Scribner, Fremont-Smith,
and Burnell [2] and Simmons and Avedon [3] felt
that plasma potassium levels in respiratory and meta-
bolic acidosis were a function of blood pH and not
plasma bicarbonate, with the former being the only
important determinant of blood potassium concen-
tration. On the other hand, studies by Leibman and
Edelman [4] demonstrated differences in transcellu-
tar potassium distribution between respiratory and
metabolic disorders. Recently, we demonstrated that
changes in the blood bicarbonate concentration
affect blood potassium concentration at a constant
blood pH (isohydric conditions) in normokalemic,
acutely hyperkalemic, and chronically hypokalemic
rats [8, 9]. To determine whether similar results
occur in humans, 18 hyperkalemic patients were
treated with i.v. sodium bicarbonate, and the effect of
this infusion on blood pH, bicarbonate, and potas-
sium was examined. The data indicate that bicarbon-
ate, separate from its effect on pH, is a major deter-
minant of extracellular potassium concentration and
should, therefore, be employed to treat hyperkale-
mia, even when blood pH is nearly or completely
compensated, provided the plasma bicarbonate con-
centration is decreased.
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Methods
Fourteen patients with hyperkalemia were treated
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with i.v. sodium bicarbonate. In each patient, a per-
cutaneous radial arterial line was inserted, and base-
line arterial blood gases and electrolytes were mea-
sured. All patients were breathing room air, and in
none was any control exerted over compensatory
respiratory efforts by either sedation, supplemental
oxygen, a respirator, or paralytic drugs. An initial
infusion of 1,000 ml of 5% dextrose and water, con-
taining two or three ampoules of sodium bicarbonate
(44.5 mEq per ampoule), was administered over four
to six hours. Each patient was asked to void at the
beginning of the infusion. Thereafter, all urine was
collected under mineral oil during the period of the
infusion. Blood for arterial blood gases and electro-
lytes was usually drawn four separate times during
the infusion, but the exact time varied with the clini-
cal situation. Further bicarbonate infusions were giv-
en those patients who still had significant hyperkale-
mia after the completion of the first infusion. Four
additional patients were given 1,000 ml of 5% dex-
trose in water i.v. over four to six hours prior to
starting an infusion of 1,000 ml of 5% dextrose con-
taining three ampoules of sodium bicarbonate, again
given over four to six hours. Blood and urine speci-
mens were collected in both the dextrose and dex-
trose plus bicarbonate periods.
Patients were divided into two groups, retrospec-
tively, depending on changes in blood pH induced by
the bicarbonate infusion. Five patients had a pH rise
of at least 0.08 pH units (changed pH group), while in
nine patients the blood pH changed less than 0.04 pH
units (constant pH group). Changes in carbon diox-
ide tension (Pco2) or plasma potassium concentra-
tions were not used to separate the two groups; the
sole criterion employed was the change in blood pH.
Blood gas determinations were made using a micro
blood gas analyzer (Radiometer BMSII MK3). Blood
bicarbonate was calculated using an alignment nomo-
gram (Siggaard-Andersen) [10], Plasma and urine
electrolytes were measured using a flame photome-
ter (Instrumentation Laboratories). Urine pH and
Pco2 were measured in the Radiometer BMSII MK3.
Urine bicarbonate was calculated from the pH and
Pco2. The data were statistically compared through-
out the study by using Student's t test for paired
data.
Results
ChangedpH group. The five patients in this group
had a mean age of 52 (21 to 84) yr. Hyperkalemia was
due to renal failure in three patients, to metabolic
acidosis in another, while in the filth patient, spirono-
lactone ingestion was probably responsible for the
elevated potassium. The bicarbonate administered
ranged between 89 and 178 mEq, with a mean value
of 125 mEq per patient. Figure 1 shows the effect of
bicarbonate infusion on blood pH, bicarbonate, and
plasma potassium in this group of patients. Mean
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Fig. 1. Blood pH, bicarbonate, and potassium changes in the
changed pH patient group. The solid and hatchedbars represent
the values before and after treatment, respectively. Each paint
represents the mean SEM for values obtained in five patients.
blood pH increased significantly (P <0.001) 0.12 pH
units, from 7.31 0.05 (sEM) to 7.43 0.04 (range,
0.08 to 0.17), associated with a significant rise in
blood bicarbonate concentration, from 17.6 2.3 to
23.5 3.2 mEq/liter (P < 0.001). The bicarbonate
increase ranged from 3.0 to 9.0 mEq/liter, while the
Pco2 remained constant at 34 mm Hg. Simultaneous-
ly, plasma potassium concentration decreased in
each patient, with a mean drop from 6.4 0.4 to 4.8
0.3 mEq (range, 1.2 to 2.1 mEq/liter). This
decrease was statistically significant (P < 0.001).
Mean initial blood sugar was 134 20 rngIlOO ml and
rose during the infusion to 146 20; the increase was
not statistically significant (P > 0.05).
Constant pH group. The nine patients in this
group had a mean age of 70.3 (51 to 96) yr. Hyperka-
lemia was due to renal failure in five patients, to
spironolactone in another, while two patients were in
congestive heart failure and on low sodium diets. A
ninth patient had a lymphoma, but the cause of the
hyperkalemia was not clear. Bicarbonate adminis-
tered ranged between 89 and 178 mEq, with a mean
value of 133 mEq per patient. The effect of bicarbon-
ate infusion on blood acid-base conditions and plas-
ma potassium in these patients is shown in Figure 2.
Blood pH rose insignificantly from its initial value of
7.35 0.01 to 7.36 0.02 (range, 0 to 0.04), while
blood bicarbonate concentration rose significantly (P
<.001), from 14.0 1.2 to 19.9 0.6 mEq/liter. The
bicarbonate increase ranged from 2.1 to 8.0 mEq/
liter; and the Pco9 also rose, from 26 1 to 37 I
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Fig. 2. Blood pH, bicarbonate, and potassium changes in the
constant pH patient group. The solid and hatched bars represent
the values before and after treatment, respectively. Each point
represents the mean SEM for values obtained in nine patients.
Change in blood bicarbonate,
rnEq/Iiter
Fig. 3. Relationship between changes in the blood bicarbonate
and serum potassium concentration in the changed pH group.
Each point represents a single value obtained during the bicarbon-
ate infusion in one of the five patients. The line was obtained by
the least squares method.
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28 Table 1, it is apparent that mean blood pH changes
26 are small to nonexistent. It is important to note that
24 • in no single patient did any blood pH value differ by
more than 0.05 pH units from the initial pretreatment
22
value. Table 1 shows that the constancy in blood pH
20 was due to proportionate increases in the blood
18 2 bicarbonate and blood carbon dioxide tensions. Fur-
ther, it shows that the plasma potassium concentra-
16 tion steadily fell as the blood bicarbonate concentra-
14 tion rose, despite the constancy of the blood pH.
12 Blood bicarbonate and plasma potassium changes
72 0 in the two groups of patients. Figure 3 depicts the1
changes in plasma potassium concentration in the
changed pH group as a function of the change in the
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mm Hg. Simultaneously, plasma potassium concen-
tration fell from its initial value of 6.3 0.3 mEq/liter
to 4.8 0.2 mEq/liter. The potassium decrease
ranged from 0.5 to 2.8 mEq/liter and was statistically
significant (P < 0.001). Changes in blood sugar were
similar to those in the other group, with an initial
blood sugar of 140 24 mg/100 ml, rising to 154
30, a nonsignificant increase.
Table 1 demonstrates the constancy of the blood
pH in this group of patients throughout the period of
bicarbonate infusion. The exact length of time for
each period is not given, since this differed between
patients; the mean time, however, was 31/2 hr
between samples. As mentioned in the methods sec-
tion, the rate and amount of bicarbonate infused
depended upon the clinical circumstances. From
Changed pH:
. slope=0.1760
r=0.6714
P<0.001
• ,-
.
.
.
SS
—1.0
—4 +4 +8 +12 +16 +20 +24
Table 1. Sequential changes in blood acid-base conditions and plasma potassium induced by bicarbonate
infusion in the constant pH group
InitiaP'
Change from initial values during and after bicarbonate infusion'
1 2 3 4 5
Arterial blood pH 7.35 0.01 —0.01 0.01 +0.00 0.01 +0.00 0.01 +0.00 0.00
(7.36)'
—0.01 0.03
(7.38g
Plasma
potassium,
mEqiliter 6.3 0.4 —0.6 0.2 —1.0 0.2 —1.1 0.2 —1.5 0.4
(6.6)e
—1.6 1.0
(6.6)c
Arterial blood
bicarbonate,
inEqiliter 14.0 1.2 +2.3 0.4 +4.9 0.7 +6.6 0.8 +7.0 1.4
(14.7)e
+10.0 2.8
(14.5)'
Arterial blood
Pco2, mm Hg 25.2 2.2 +4.8 0.7 +8.8 1.1 +11.5 1.6 +11.9 2.3
(26.6)c
+18.2 8.1
(25.1)c
Nd 9 9 9 9 7 2
Each value represents the mean SEM prior to bicarbonate infusion.
Each value represents the mean SEM of the difference from the initial value.
Numbers in parentheses indicate initial values on the seven or two patients in the group.
N denotes the number of patients.
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blood bicarbonate concentration. There is a positive
correlation (P < 0.001) between the plasma potas-
sium and blood bicarbonate changes determined at
various times during the bicarbonate infusion. For
each rise of 1 mEq of blood bicarbonate, plasma
potassium concentration falls 0.18 mEq/liter. A simi-
lar linear function is also described by the data from
the constant pH patient group. These data are shown
in Figure 4. In this group, a rise in blood bicarbonate
Fig. 4. Relationship between changes in the blood bicarbonate
and serum potassium concentration in the constant pH group.
Each point represents a single value obtained during the bicarbon-
ate infusion in one of the nine patients. The line was obtained by
the least squares method. The dotted line is the changed pH group
line derived in Figure 3, while the solid line represents the con-
stant pH regression line.
of 1 mEq/liter is accompanied by a fall in plasma
potassium concentration of approximately 0.13 mEqI
liter. The regression lines in these two groups were
compared by covariance analysis (F test). As shown
in Figure 4, not only do these lines appear similar,
but by covariance analysis, no statistical difference
exists between the residual mean squares of the
lines, their slopes, or their X intercepts.
Urinary potassium loss. To determine whether the
plasma potassium decrease was due to body potas-
sium loss, this parameter was examined. No patient
had significant diarrhea or other gastrointestinal fluid
losses. As some patients did have adequate urinary
output over the period of bicarbonate infusion, how-
ever, urinary potassium loss over the entire time of
the study was compared to changes in the plasma
potassium concentration. These data were unobtain-
able for one patient from each group, as the urines
were inadvertently discarded. The results in the
remaining twelve patients are shown in Figure 5. It
can be seen that there is no correlation between the
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Fig. 5. Relationship between urinary potassium excretion and
decreased seru,n potassium concentration in changed and con-
stant pH patients. Each of the circles represents the data obtained
in one of the four changed pH patients, while the diamonds are the
values obtained in the eight constant pH patients. The urinary
potassium excretion in each patient represents the total amount
excreted over the duration of the study.
total potassium excreted and the fall in the plasma
potassium concentration in either group of patients.
Of great interest are the six patients in whom total
potassium excretion was less than II mEq. Four of
these patients (three of whom were essentially an-
uric) were in the constant pH patient group. In all six
patients, plasma potassium concentration fell at least
1.1 mEq/liter. Mean urinary potassium excretion per
patient in the two groups was 29 mEq—too small to
account for any significant portion of the observed
decrease in plasma potassium concentration.
Dextrose's effect on plasmapotassium concentra-
tion. In each of the 14 patients studied, bicarbonate
was infused in 5% dextrose and water. All patients
received, therefore, at least 50 g of dextrose in addi-
tion to the bicarbonate. As dextrose is known to
decrease plasma potassium, it is possible, though not
probable, that the sugar could have been partially
responsible for the dramatic fall in the plasma potas-
sium concentration. To evaluate this possibility, four
additional hyperkalemic patients were studied. Each
patient received 1,000 ml of 5% dextrose in water
over a four- to six-hour period. This was followed by
another 1,000 ml of this solution containing bicarbon-
ate, also given for four to six hours. In two patients,
blood pH rose by more than 0.06 pH units, while in
the two others, blood pH remained constant through-
out the eight- to ten-hour time period. The effect of
the two infusions on these four patients' plasma
potassium concentration is shown in Table 2. It is
obvious that glucose alone did not significantly
reduce the plasma potassium concentration. Indeed,
in two patients, plasma potassium concentration
rose. The identical amount of dextrose infused with
+4.0
+3.0
E0
00.
a,
C,a,0
0
+2.0
+1.0
70 80
—1
+12 +16 +20 +24
Change in blood bicarbonate. mEq/Iirer
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Table 2. Comparison ofthe effect of dextrose (D5W) alone to dex-
trose plus sodium bicarbonate (D5W + NaHCO3) on plasma potas-
sium concentration (K) in four patients with hyperkalemia
Patient
PretreatmentK
After D5W After D5W + NaHCO3
K K* K
no. mEqi/iter nEqIIiter ,-nEq/Iiter mEqlliter mEqiliter
1 6.2 7.0 +0.8 4.6 —2.4
2 7.1 8.0 +0.9 6.0 —2.0
3 6.4 6.1 —0.3 5.1 —1.0
4
X so 6.86.6 0.4
6.0
6.8 0.9
—0.8
+0.2 0.8
4.3
5.0 0.7
—1.7
—1.8 0.6'
No statistical significance with P value of >0.05.
Statistically significant at <0.01.
bicarbonate significantly reduced the plasma potas-
sium concentration in each of the four patients. Uri-
nary potassium loss was small in three patients,
while one patient exhibited virtual anuria during the
study period. From these data, it is apparent that the
bicarbonate-induced fall in the plasma potassium
concentration in the original 14 patients cannot be
ascribed to the dextrose they were given.
Discussion
Hyperkalemia is a life-endangering electrolyte dis-
order, manifested by profound muscle weakness and
disturbances in cardiac conduction [11, 12].
Although usually caused by decreased potassium
excretion in renal failure, it is also seen in congestive
heart failure patients, especially those ingesting salt
substitutes or low-sodium dietetic foods, and in
patients taking diuretics which block renal potassium
secretion, such as spironolactone or triamterene.
Finally, hyperkalemia is also seen in acute acidosis.
In this condition, the elevated plasma potassium con-
centration is primarily caused by a shift of potassium
from the intracellular to the extracellular compart-
ment. Since 98% of body potassium is located intra-
cellulary [131, relatively small shifts of potassium
from this space will result in large changes in blood
potassium concentration.
Bicarbonate is often administered i.v. in severe
acidosis to treat hyperkalemia [5—71 since correction
of the acidosis by bicarbonate purportedly drives
potassium into the cell, thus, decreasing the plasma
potassium concentration. This was initially proposed
by Fenn and Cobb in 1934 [1] and later substantiated
by Scribner et al [2]. The latter investigators demon-
strated that acute respiratory acidosis in dogs, unac-
companied by a significant change in the blood bicar-
bonate concentration, raised the serum potassium
and prevented infused potassium from entering cells.
With the exception of one study [3], most experi-
ments in dogs, however, indicate that significant ele-
vations in the plasma potassium concentration
induced by respiratory acidosis require greater than
physiologic elevations in the carbon dioxide tension
[14]. The effect of carbon dioxide elevation on plas-
ma potassium in rats and humans, however, appears
to be much greater. Fraley and Adler [91 demonstrat-
ed that in rats, raising the Pco2 from 36 to 70 mm Hg
increased the plasma potassium concentration 1.4
mEq/liter. Studies by Burnell et al [15] and Kilburn
[16] in humans gave results similar to the rat data,
showing that physiologic elevations of carbon diox-
ide tension were accompanied by significant increas-
es in the plasma potassium concentration. In Kil-
burn's study, for example, when acute respiratory
acidosis reduced the blood pH from 7.40 to 7.10, the
plasma potassium concentration rose 1.8 mEq/liter.
Thus, it is clear that in both rat and man, respiratory-
induced physiologic changes in blood pH alter the
plasma potassium concentration. Contrary to the
demonstrable effect of extraceliular pH, the indepen-
dent role of bicarbonate in the regulation of plasma
potassium concentration remains unsettled. Lieb-
man et al [41 found a greater correlation between
serum potassium concentration and extracellular pH
in metabolic than in respiratory acid-base disorders
and suggested that bicarbonate was an important
regulator of serum potassium concentration. In
hypertonically expanded nephrectomized dogs,
Makoff, DaSilva, and Rosenbaum [17] demonstrated
that changes in serum potassium did not correlate
with changes in extracellular pH, but appeared to be
a function of alterations in extracellular bicarbonate,
though the hypertonicity itself may have been par-
tially responsible for the change. Supporting data
were presented by Kim and Brown [181, who found
that isohydric lowering of the blood bicarbonate con-
centration in nephrectomized dogs raised the serum
potassium concentration. On the other hand, Sim-
mons and Avedon [3] reported that under isohydric
conditions, extracellular bicarbonate concentration
had no effect on serum potassium in dogs. Their
experimental period, however, was short. Recently,
we demonstrated [8, 9] that in normokalemic, acute-
ly hyperkalemic, or chronically hypokalemic rats
isohydric alterations in blood bicarbonate concentra-
tion markedly affected the plasma potassium concen-
tration. Lowering bicarbonate raised plasma potas-
sium, while raising bicarbonate decreased its
concentration. The present results show that bicar-
bonate, separate from its effect on pH, is also an
important regulator of plasma potassium concentra-
tion in man, since the change in plasma potassium
concentration induced by bicarbonate was identical
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in both the changed and constant pH groups. The
differences in the blood carbon dioxide tensions
between the two groups were noted. The exact rea-
sons for these observed differences in respiratory
response are unknown. It is possible that changes in
the central nervous system's pH account for the
results, but unfortunately spinal fluid or cisternal
fluid acid-base values could not be obtained. Though
the proportional increases in Pco2 and bicarbonate
maintained the pH constant in the one group, and the
lack of change in Pco2 in the other group was associ-
ated with pH change in that group, the carbon diox-
ide tension cannot itself explain the changes in potas-
sium concentration.
Two mechanisms might explain the observed
effect of bicarbonate on plasma potassium. First,
bicarbonate acting as a nonreabsorbable anion might
increase potassium excretion [19]. This mechanism
cannot explain the present results. As the data in
Figure 5 demonstrate, little potassium was excreted
in either patient group, and some patients decreased
their plasma potassium levels despite virtual anuria.
The second possibility is that bicarbonate ions
altered the transcellular distribution of potassium.
Similar changes of extracellular potassium concen-
tration are seen with peritoneal dialysis, where the
actual movement of potassium is small and the
majority of the change is due to the movement of
potassium into cells [20]. Schwartz et a! [5] similarly
noted that the correction of hyperkalemia with bicar-
bonate therapy did not depend on the renal excretion
of potassium. In these and other studies, however,
the decrease in plasma potassium was accompanied
by a rise in blood pH, and the bicarbonate and pH
effects could not be separated. The present study
clearly shows that bicarbonate, without changing the
blood pH, alters plasma potassium by an extrarenal
mechanism, presumably shifting extracellular potas-
sium intracellularly. As the regression lines for both
the changed and constant pH groups are indistin-
guishable, it appears that under the conditions of this
experiment the change in bicarbonate, not the
change in pH, was the major factor regulating plasma
potassium.
Many forms of therapy have been advocated for
the treatment of hyperkalemia. Hypertonic glucose
and insulin transfer extracellular potassium into
cells, but the effect is variable and unsustained [6, 7].
Ion exchange resins are also commonly employed,
but the effect is slow, and the treatment, especially
when the resin must be given by enema, is discomfit-
ing to both patients and nursing staff. Other buffers,
such as Tris, have been used to raise blood pH and
drive extracellular potassium back into cells. How-
ever, not only is administration of this drug often
painful, but there is no evidence that Tris exerts the
pH-independent effect on plasma potassium which
the animal [8, 9] and present experiments demon-
strate is a function of bicarbonate. It should be men-
tioned that although bicarbonate was given in 5%
dextrose, the fall in plasma potassium was not due to
the dextrose itself, since in the four hyperkalemic
patients given dextrose alone no significant fall in
plasma potassium was found. The data, therefore,
support the use of bicarbonate as the most effective
emergency treatment for hyperkalemia, even in the
presence of compensated acid-base disorders and
renal failure, provided the bicarbonate concentration
is decreased.
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